ArabFinance:  Arab Drug Company (ADCI) posted a net profit EGP 25.672 million for the three-month period ended in September 2021, compared EGP 31.72 million in the same period of 2020, according to the company’s unaudited financials to the Egyptian Exchange (EGX).

The company’s profit before taxes recorded EGP 33.125 million for the July-September period of 2021, compared to EGP 40.9 million in the same period last year.

The company’s total sales recorded EGP 150.76 million by the end of September 2021, compared to EGP 148.75 million in September 2020. 

Arab Drug is an Egypt-based company engaged in the pharmaceutical sector. The company focuses on the manufacture, packaging, and distribution of pharmaceutical products as well as chemical solutions for human and veterinary use.